NDC11 62032092201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 62032-0922-01 | 62032-0922 |
| 62032-0922-1 | 62032-0922 |
| 62032-922-01 | 62032-922 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Obagi-C C-Rx System Normal-Dry Skin Intervention | HYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDE | Obagi Cosmeceuticals LLC | e9d8488f-b902-45f4-a6d6-c6eb393c8f08 | 2025-11-13 | Warnings | 62032-922-01 62032-922 62032092201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.